Opicinumab (BIIB033) is a novel monoclonal antibody against LINGO-1 that may be used to prevent and delay acute optic neuritis and recurrent multiple sclerosis.
CAS Number:
[1422268-07-2]
Target:
BIIB033
* VAT and and shipping costs not included. Errors and price changes excepted